Researchers are continuously conducting studies with stem cells or engineered tissues that have shown effectiveness in treating previously untreatable diseases. According to Pharmaceutical Research and Manufacturers of America, more than 362 cell and gene therapy products are in clinical development by biopharmaceutical companies in the U.S. For instance, Kite, a Gilead Company is conducting a study to evaluate whether axicabtagene ciloleucel therapy improves the clinical outcome compared with standard of care second-line therapy in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Similarly, Lattice Biologics Ltd. is conducting a study for developing novel stem cell technology, AmnioBoost, for the treatment of COVID-19 infection.

To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/regenerative-medicine-market/7671

Although gene and cell therapies are more effective than traditional medicines or treatments, the cost of these therapies is quite higher and this is one of the major factors restraining the market growth. As a series of procedures are conducted using stem cells, this tends to increase the overall treatment cost. Moreover, at present, insurance coverage is very low for these treatments. Thus, such factors are hindering the market growth of the regenerative medicine market.

Some of the prominent players operating in the Dental Equipment & Consumables Market includes: -
• 3M
• Allergan
• Gilead Sciences, Inc
• Bristol-Myers Squibb Company
• Integra LifeSciences Corporation
• Amgen Inc
• Novartis AG
• Medtronic
• Spark Therapeutics, Inc
• Stryker
• among others

Browse the full report now: https://growthplusreports.com/report/regenerative-medicine-market/7671
About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.